Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial
Date issued
2013Journal title
EUROPEAN JOURNAL OF CANCER
Type of content
Publicación de congreso